Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, et al
Lancet Gastroenterol Hepatol. 2018 Jan 5
Abstract
Treatment with direct-acting antiviral agents of hepatitis C virus infection in
injecting drug users: a prospective study.
Boglione L,
Mornese Pinna S, et al
J Viral
Hepat. 2017 Mar 26.
Abstract
FULL-TEXT ARTICLE
Facilitators of HCV treatment adherence among people who inject
drugs: a systematic qualitative review and implications for
scale up of direct acting antivirals.
Rich ZC, Chu C, Mao J,
et al
BMC Public Health.
2016 Sep 20;16
Paper
FULL-TEXT
ARTICLE
Spontaneous viral clearance of hepatitis C virus (HCV) infection
among people who inject drugs (PWID) and HIV-positive men
who have sex with men (HIV+ MSM): a systematic review and
meta-analysis.
Smith DJ, Jordan AE, Frank M, Hagan H.
BMC Infect Dis.
2016 Sep 5;16:471.
Paper
FULL-TEXT ARTICLE
Are Interferon-Free Direct-Acting Antivirals for the Treatment
of HCV Enough to Control the Epidemic among People Who Inject
Drugs?
Lima VD, Rozada I, Grebely J, et al
PLoS One.
2015 Dec 3;10(12):e0143836
Paper
Drug-drug interactions in the treatment of HCV
among people who inject drugs.
Mauss S, Klinker H.
Clin Infect Dis. 2013
Aug;57 Suppl 2:S125-8.
Abstract
Combination therapy of natural human
interferon-beta and ribavirin for chronic hepatitis C patients
with injection drug use.
Morikawa H, Kozuka R, Fujii H, et al
Hepatol Res. 2013 Mar 27
Abstract
|
Addiction
Therapy
IDU
HCV
Main Page
Documents identified with this icon are in
Portable Document Format (PDF) and require the
Adobe
Acrobat Reader